Cast light Health Inc. (NYSE:CSLT) saw its quiet period end. The big data player for health care was started as Neutral at Goldman Sachs, as Outperform at Raymond James, as Buy at Stifel and as Buy at Canaccord Genuity. Cast light Health Inc (NYSE:CSLT) shares after opening at $19.21 moved to $19.43 on last trade day and at the end of the day closed at $18.31. Company price to sales ratio in past twelve months was calculated as 121.93 and price to cash ratio as 23.59. Cast light Health Inc (NYSE:CSLT) showed a negative weekly performance of -18.77%.
A number of research firms have recently commented on Guide wire Software Inc (NYSE:GWRE). Analysts at Zacks upgraded shares of Guide wire Software from a “neutral” rating to an “outperform” rating in a research note on Friday, March 7th. Guide wire Software Inc (NYSE:GWRE) shares fell -8.11% in last trading session and ended the day on $198.80. GWRE return on equity ratio is recorded as -0.40% and its return on assets is -0.50%.Guide wire Software Inc (NYSE:GWRE) yearly performance is 15.43%.
One stock that might be an intriguing choice for investors right now is Intrexon Corporation (NYSE:XON). This is because this security in the medical services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. Intrexon Corp (NYSE:XON) shares moved down -9.00% in last trading session and was closed at $21.75, while trading in range of $ 21.47 – $23.85. Intrexon Corp (NYSE:XON) year to date (YTD) performance is -8.61%.
Cloud-based e-commerce provider Channel Advisor Corporation (NYSE:ECOM) has announced the promotion of Jordan Weinstein to the role of managing director, EMEA. Along with this appointment, Channel Advisor has expanded its European management team with four new directors in the EMEA region. Channel Advisor Corp (NYSE:ECOM) weekly performance is -10.13%. On last trading day company shares ended up $31.22. Channel Advisor Corp (NYSE:ECOM) distance from 50-day simple moving average (SMA50) is -24.15%. Analysts mean target price for the company is $46.86.